Back
Aprea Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
30
APRE
Aprea Therapeutics
Last Price:
2.60
Seasonality Move:
-39.53%
Sell
42
NBY
NovaBay Pharmaceuticals
Last Price:
0.71
Seasonality Move:
-19.92%
Sell
30
Aprea Therapeutics (APRE)
is a Sell
Is Aprea Therapeutics a Buy, Sell or Hold?
- The current Aprea Therapeutics [APRE] share price is $2.60. The Score for APRE is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- APRE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.71. The Score for NBY is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
APRE Stock Price Chart
What is Aprea Therapeutics's stock price today?
-
The Aprea Therapeutics share price today is $2.60
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APRE is experiencing selling pressure, which indicates risk of future bearish movement.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.71
The current trend is relatively stagnant and NBY is experiencing selling pressure, which indicates risk of future bearish movement.
APRE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.21 | Sell |
Relative Strength Index (14 RSI): | 33.15 | Sell |
Chaikin Money Flow: | -13903 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.78 - 3.32) | Sell |
Bollinger Bands (100): | (3.14 - 4.58) | Sell |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 55.73 | Buy |
Chaikin Money Flow: | -66635 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.46 - 0.7) | Buy |
Bollinger Bands (100): | (0.33 - 3.11) | Sell |
APRE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.73 | Sell |
20-day SMA: | 2.96 | Sell |
50-day SMA: | 3.31 | Sell |
200-day SMA: | 4.86 | Sell |
8-day EMA: | 2.74 | Sell |
20-day EMA: | 2.94 | Sell |
50-day EMA: | 3.3 | Sell |
200-day EMA: | 4.5 | Sell |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.71 | Buy |
20-day SMA: | 0.61 | Buy |
50-day SMA: | 0.55 | Buy |
200-day SMA: | 3.29 | Sell |
8-day EMA: | 0.7 | Buy |
20-day EMA: | 0.65 | Buy |
50-day EMA: | 0.87 | Sell |
200-day EMA: | 7.55 | Sell |
Aprea Therapeutics Earnings Growth & APRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.69 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.21 per share, and an increase next year of $2.56 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.
Aprea Therapeutics Technical Analysis
Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |